Related Experiment Video
Updated: Apr 4, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice
Lin-lin Shi1, Yuan Li1, Yuan Wang1
1Engineering Research Center of Modern Preparation Technology of TCM, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.
Abstract:
Most plant polysaccharides cannot be digested and utilized by host enzymes, and must be subjected to microbial fermentation before being assimilated by the host. MDG-1, a water-soluble β-d-fructan extracted from the roots of Ophiopogon japonicus, has potent anti-obesity and hypoglycemic effects. Interestingly, we found that MDG-1 is hardly absorbed into the blood. We presumed that MDG-1 might exhibit its potent efficacy via regulating the gut microbiota of the host. However, the overall microbiota structure variation of obese mice treated with MDG-1 and the direct metabolic consequences of MDG-1 on specific microbiota phyla remain poorly understood. Here, obese male C57BL/6 mice induced by a high-fat diet were given either vehicle or MDG-1 at a dose of 300mg/kg for 12 weeks and the overall fecal gut microbiota structure change was analyzed via pyrosequencing. On this basis, we further separated and identified the dominant bacteria of the feces from the MDG-1 treated mice. These bacteria were then cultured with MDG-1 in vitro and their metabolic profiles were analyzed via a metabonomic approach. The results showed that MDG-1 could decrease the ratio of Firmicutes/Bacteroidetes, adjust the abnormal gut microbiota to the normal state and alter their metabolic profiles. In addition, we identified that the indigestible MDG-1 could be degraded and utilized by gut microbiota that could, in turn, be assimilated and used by the host, where it exerted weight loss effects, energy metabolism promotion and boosted the immune system effectiveness.
Insights
MDG-1, a fructan from Ophiopogon japonicus, aids weight loss by altering gut microbiota. This indigestible compound is fermented by gut bacteria, which then provide beneficial metabolites to the host, promoting health.
Area of Science:
- Microbiology
- Nutrition Science
- Metabolomics
Background:
- Plant polysaccharides require microbial fermentation for host assimilation.
- MDG-1, a β-d-fructan from Ophiopogon japonicus, shows anti-obesity and hypoglycemic effects but poor absorption.
- The mechanism of MDG-1's efficacy via gut microbiota regulation is not fully understood.
Purpose of the Study:
- To investigate the impact of MDG-1 on gut microbiota structure in obese mice.
- To determine the metabolic consequences of MDG-1 on specific gut bacteria.
- To elucidate how MDG-1 exerts its beneficial effects through gut microbiota interaction.
Main Methods:
- Obese mice fed a high-fat diet were treated with MDG-1 (300mg/kg) or vehicle for 12 weeks.
- Fecal gut microbiota structure was analyzed using pyrosequencing.
- Dominant bacteria were cultured with MDG-1 in vitro, and their metabolic profiles were analyzed using metabonomics.
Main Results:
- MDG-1 treatment decreased the Firmicutes/Bacteroidetes ratio, normalizing gut microbiota.
- MDG-1 altered the metabolic profiles of gut bacteria.
- Indigestible MDG-1 was utilized by gut microbiota, producing host-assimilable metabolites.
Conclusions:
- MDG-1 effectively modulates gut microbiota composition and function in obese mice.
- Gut microbiota fermentation of MDG-1 contributes to its anti-obesity, metabolic, and immune-boosting effects.
- MDG-1 represents a promising prebiotic for managing obesity and metabolic dysfunction through gut microbiota manipulation.
Related Concept Videos
Functions of the Gut Microbiota
Microbiota of the Large Intestine
Gut-Brain Axis

